Soluble forms of CD21 and CD23 antigens in the serum in B cell chronic lymphocytic leukaemia
- 1 January 1989
- journal article
- research article
- Published by Elsevier in Immunology Letters
- Vol. 20 (2) , 103-109
- https://doi.org/10.1016/0165-2478(89)90093-x
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Immunobiology of CR2, the B Lymphocyte Receptor for Epstein-Barr Virus and the C3d Complement FragmentAnnual Review of Immunology, 1988
- Soluble CD23 is released by B lymphocytes cycling in response to interleukin 4 and anti‐Bp50 (CDw40)European Journal of Immunology, 1988
- Human recombinant interleukin 4 induces normal B cells to produce soluble CD23/IgE‐binding factor analogous to that spontaneously released by lymphoblastoid B cell linesEuropean Journal of Immunology, 1988
- Activated lymphocytes during acute Epstein-Barr virus infection.The Journal of Immunology, 1987
- EPSTEIN-BARR VIRUS RECEPTORS ON HUMAN PHARYNGEAL EPITHELIAThe Lancet, 1986
- Evidence for an association between CD23 and the receptor for a low molecular weight B cell growth factorEuropean Journal of Immunology, 1986
- Soluble interleukin 2 receptors are released from activated human lymphoid cells in vitro.The Journal of Immunology, 1985
- Early events in Epstein-Barr virus infection provide a model for B cell activation.The Journal of Experimental Medicine, 1985
- Expression of C3d receptors during human B cell differentiation: immunofluorescence analysis with the HB-5 monoclonal antibody.The Journal of Immunology, 1984
- Release of Ia antigens by a cultured B cell line.The Journal of Immunology, 1980